Share This Page
Explore the Possibilities
and Advance with Us.
Post Doctoral Associate
Job Number: 2021-37404
Category: Post Doc
Location: Worcester, MA
Shift: Day
Exempt/Non-Exempt: Exempt
Business Unit: UMass Chan Medical School
Department: School - Molecular Medicine - Diabetes - W400950
Job Type: Full-Time
Salary Grade: 86
Union Code: Non Union Position-W63-Residents/Post Docs
Num. Openings: 1
Post Date: March 7, 2021

We are seeking a highly motivated individual for a postdoctoral fellow position in the Program of Molecular Medicine and Diabetes Center of Excellence at the University of Massachusetts Chan Medical School. The Maehr laboratory focuses on human pluripotent stem cell-based disease models to investigate and to find novel treatment strategies for immune syndromes, such as Type 1 diabetes.

Responsibilities

You will participate in research centered around the modeling of immune syndromes with human pluripotent stem cells (induced pluripotent stem cells, embryonic stem cells, and stem or progenitor cell-derived organoids). Your responsibilities are to perform experiments, including stem and immune cell culture and differentiation, CRISPR-based mechanistic studies, molecular and immunological analyses, and xenograft experiments in mice). You are expected to analyze and present data in lab meetings, departmental and institutional work-in-progress seminars and national and international conferences. Further, you will prepare manuscripts and help with preparation of grant applications under guidance of the PI.

Qualifications

Candidates should possess a Ph.D. in biological sciences. Experience in immunology, stem cell biology and/or functional genomics are a plus. Excellent communication, writing, and collaboration skills are essential. 

Interested candidates should email a cover letter, CV and name of three references to Dr. René Maehr (rene.maehr@umassmed.edu). 

Check Out Our Advancing Careers 
HR Blog

UMass Chan Medical School was among 23 companies that stood out as 2023 “DEI champions,” according to The Boston Globe.   


Named a U.S. News & World Report
“2023 BEST MEDICAL GRAD SCHOOL”
for Primary Care and Research